Electroceuticals Market

Report Code MD 4358
Published in Mar, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Electroceuticals Market / Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) & Region - Global Forecast to 2029

Overview

The global electroceuticals market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. In recent years, there has been a rapid advancement in medical technology, leading to significant changes in therapies and medicine. This progress has contributed to the substantial growth of the bioelectric medicine market. The market is expected to be driven by ongoing developments in the healthcare sector and the increasing integration of technology in medical applications.

Attractive Opportunities in the Electroceuticals Market

ASIA PACIFIC

The Asia Pacific market is expected to witness high growth during the forecast period owing to the growing focus on healthcare and advancements in electroceuticals technologies.

Growth of the overall market is largely driven by the increasing incidence of cardiovascular, hearing loss and neurological disorders, increasing research in these field of disorders, and rising awareness regarding electroceuticals devices.

Product launches and approvals were the most widely adopted growth strategies by market players.

The North American market is projected to hold the largest market share during the review period.

Emerging markets are expected to offer lucrative growth opportunities for players in the electroceuticals market.

Global Electroceuticals Market Dynamics

DRIVER: The increasing elderly population and subsequent rise in the prevalence of neurological and cardiovascular disorder

The geriatric population is more susceptible to developing neurologic or cardiovascular disorders, making them a significant segment of the patient pool. This population segment's growth will drive continued and increased demand for electroceutical devices like cardiac pacemakers, implantable cardioverter defibrillators, deep brain stimulators, and spinal cord stimulators for treating cardiovascular and neurological disorders.

RESTRAINT: The high cost associated with electroceutical devices

The high cost of electroceutical devices like cochlear implants and neurostimulators is a significant factor limiting market growth, especially in price-sensitive regions such as the Asia Pacific, Latin America, and Africa. Healthcare providers in developing countries like Brazil and Mexico often have limited financial resources for investing in advanced technologies. Additionally, extensive training is required for staff to efficiently handle and maintain these devices. Furthermore, the development of technologically advanced electroceutical devices, such as cochlear implants, necessitates extensive R&D efforts, leading to increased manufacturing costs. This requires substantial capital investment, which may only be feasible for established or major players in the market. Moreover, the market is dominated by large, well-established players with high brand loyalty, making it challenging for new entrants to compete unless they can differentiate themselves through innovative product offerings.

 

OPPORTUNITY: Emerging markets present attractive opportunities.

Emerging economies like India, South Korea, Malaysia, Vietnam, various African nations, and Middle Eastern countries such as Israel, Saudi Arabia, and the UAE present substantial growth prospects for major market participants. This is due to their minimal regulatory hurdles, enhancements in healthcare infrastructure, expanding patient bases, and increasing healthcare spending. Moreover, regulatory frameworks in the Asia Pacific region are more flexible and conducive to business compared to developed nations. Consequently, heightened competition in mature markets has prompted leading players in the electroceuticals/bioelectric medicine market to shift their focus toward these emerging economies.

CHALLENGE: The shortage of skilled professionals

The proper placement of electroceutical devices like neurostimulators requires the expertise of neurosurgeons specialized in neural implant procedures, often with a functional neurosurgery fellowship. However, there is currently a significant gap between the demand and supply of such neurologists globally. This shortage is expected to be a concern due to the projected increase in healthcare demand driven by factors such as a growing patient population and rising disease prevalence. One of the major limitations is the challenge of producing an adequate number of trained neurosurgeons within a short timeframe. The scarcity of skilled staff, including neurologists and neurosurgeons, in key regions worldwide is anticipated to have a negative impact on the number of neurosurgery procedures performed each year, affecting the market demand for electroceutical devices like neurostimulators.

Global Electroceuticals Market Ecosystem Analysis

 

 

In 2022, implantable electroceutical devices segment accounted for the largest share in the electroceuticals industry, by type

The electroceuticals market is segmented into implantable electroceutical devices and non-invasive electroceutical devices based on type. In 2022, implantable devices offer long-lasting effectiveness, precise targeting, and reduce the need for medication. The rising prevalence of chronic diseases and a growing elderly population are expected to drive demand for these devices in the future.

In 2022, cardiac pacemakers & implantable cardioverter defibrillators accounted for the largest share of the electroceuticals industry, by product

The electroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, neuromodulators, cochlear implants, and retinal implants. based on product. The cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share of the bioelectric medicine market in 2022. The segmental growth of the market is driven by the high prevalence of sudden cardiac arrest (SCA), which often leads to arrhythmia and mortality. According to the US Centers for Disease Control and Prevention, over 350,000 people experience out-of-hospital cardiac arrest in the US alone. Electroceuticals are utilized in various applications to prevent and treat cardiac arrest, with cardiac pacemakers and implantable cardioverter defibrillators (ICDs) being used to manage arrhythmia.

NORTH AMERICA region holds the largest share of the Electroceuticals Market.

The global electroceuticals market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, the North American region emerged as the global leader in the bioelectric medicine market, driven by the presence of numerous major market players and widespread adoption of advanced medical technology. The market in this region is expanding due to a growing focus on technological advancements in the healthcare sector and the increasing prevalence of chronic diseases such as diabetes, cardiovascular disease, hearing loss, and neurological disorders.

 
 

Recent Developments of Electroceuticals Market industry

  • In January 2024, Medtronic plc (Ireland) received FDA approval of its Percept RC Deep Brain Stimulation (DBS) system. In July 2023, Boston Scientific Corporation (US) received the US FDA approval for the vercise neural navigator 5 software, which when used as part of the vercise genus deep brain stimulation (dbs) systems.
  • In May 2023, Abbott (US) received US FDA approval for its spinal cord stimulation (SCS) devices for the treatment of chronic back pain. In Dec 2022, ElectroCore (US) launched a new wellness product offering called Truvaga for customers residing in the US. Truvaga is a handheld non-invasive vagus nerve stimulator that utilizes our proven technology to quickly and gently activate the vagus nerve.

Key Market Players

KEY PLAYERS IN THE Electroceuticals Market INCLUDE

Want to explore hidden markets that can drive new revenue in Electroceuticals Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $23.9 billion
Projected Revenue by 2029 $33.6 billion
Revenue Rate Poised to Grow at a CAGR of 7.0%
Market Driver The increasing elderly population and subsequent rise in the prevalence of neurological and cardiovascular disorder
Market Opportunity Emerging markets present attractive opportunities.Y45

Key Questions Addressed by the Report

What is the projected market revenue value of the global electroceuticals market?
The global electroceuticals market is expected to reach $33.6 billion by 2029.
What is the estimated growth rate (CAGR) of the global electroceuticals market?
The market is projected to grow at a CAGR of 7.0%, with an estimated revenue size of $23.9 billion in 2024.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Electroceuticals Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
34
RESEARCH METHODOLOGY
39
EXECUTIVE SUMMARY
51
PREMIUM INSIGHTS
54
MARKET OVERVIEW
57
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising geriatric population and subsequent growth in prevalence of neurological and cardiovascular disorders
    - Rising government support and funding for neurological disorders
    - Increasing investments and funding for research on CRM devices
    - Increasing focus on development of advanced neuromodulation and cardiac devices
    - Increasing collaborations among device manufacturers, healthcare providers, and research institutes to develop neuromodulation and cardiac devices
    - Availability of reimbursements for neuromodulation, cardiac devices, and cochlear implants
    - Growing prevalence of hearing loss and increasing adoption of smart hearing aids
    RESTRAINTS
    - High cost of electroceutical devices
    - Preference for drug therapies over neuromodulation and cardiac products
    - Adverse effects and complications associated with neuromodulation, cardiac devices, and cochlear implants
    OPPORTUNITIES
    - Emerging markets
    - Development of ICDs and MRI-compatible ICDs and CRT-Ds
    - Integration with digital health platforms
    CHALLENGES
    - Dearth of trained professionals
    - Challenges associated with battery life and device replacement
    - Complexity and infection issues related to electroceutical devices
    TRENDS
    - Role of artificial intelligence (AI) in electroceutical devices
    - Wearable and portable electroceuticals
  • 5.3 PRICING ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS OF ELECTROCEUTICALS MARKET
    ROLE IN ECOSYSTEM
    KEY PLAYERS IN ELECTROCEUTICALS MARKET
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    THREAT OF SUBSTITUTES
  • 5.8 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - China
    - Japan
    - India
  • 5.9 TECHNOLOGY ANALYSIS
  • 5.10 TRADE ANALYSIS
    IMPORT SCENARIO FOR PACEMAKERS
    EXPORT SCENARIO FOR PACEMAKERS
    IMPORT SCENARIO FOR COMPLIANT PRODUCTS
    EXPORT SCENARIO FOR COMPLIANT PRODUCTS
  • 5.11 PATENT ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
ELECTROCEUTICALS MARKET, BY PRODUCT
85
  • 6.1 INTRODUCTION
  • 6.2 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    INTRODUCTION OF LEADLESS AND MRI-SAFE PACEMAKERS & DEFIBRILLATORS TO BOOST MARKET GROWTH
  • 6.3 COCHLEAR IMPLANTS
    INCREASING PREVALENCE OF HEARING LOSS TO DRIVE DEMAND
  • 6.4 NEUROMODULATORS
    SPINAL CORD STIMULATORS
    - Growing incidence of spinal cord injuries to support market growth
    DEEP BRAIN STIMULATORS
    - Widely used to control debilitating symptoms caused by movement and neurological disorders
    VAGUS NERVE STIMULATORS
    - High incidence of epilepsy to drive market
    SACRAL NERVE STIMULATORS
    - Widening scope of sacral nerve stimulation to drive growth
    GASTRIC ELECTRICAL STIMULATORS
    - Growing number of people suffering from severe GERD and gastroparesis to fuel market growth
    TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
    - Extensive use in healthcare, low cost, and ease of use to favor market growth
    TRANSCRANIAL MAGNETIC STIMULATORS
    - Minimal patient discomfort associated with TMS to support demand
    RESPIRATORY ELECTRICAL STIMULATORS
    - Increasing incidence of spinal cord injuries to drive market
    TRIGEMINAL NERVE STIMULATORS
    - High treatment efficacy to fuel market growth
    RESPONSIVE NEUROSTIMULATORS
    - Targeted and personalized treatment to fuel market growth
  • 6.5 RETINAL IMPLANTS
    GROWING NUMBER OF RETINITIS PIGMENTOSA CASES TO SUPPORT MARKET GROWTH
ELECTROCEUTICALS MARKET, BY TYPE
132
  • 7.1 INTRODUCTION
  • 7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES
    LONG-TERM COST SAVINGS TO DRIVE MARKET
  • 7.3 NONINVASIVE ELECTROCEUTICAL DEVICES
    EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COST TO SUPPORT MARKET GROWTH
ELECTROCEUTICALS MARKET, BY APPLICATION
141
  • 8.1 INTRODUCTION
  • 8.2 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY APPLICATION
    ARRHYTHMIA
    - Increasing prevalence of arrhythmia to support market growth
    HEART FAILURE
    - Rising prevalence of heart-related conditions in older individuals to drive growth
    OTHER CARDIAC PACEMAKER & ICD APPLICATIONS
  • 8.3 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION
    CHRONIC PAIN
    - High incidence of chronic pain to support market growth
    FAILED BACK SURGERY SYNDROME
    - Increasing incidence of FBSS to drive demand
    ISCHEMIA
    - High effectiveness of neuromodulation for ischemia treatment to propel market
  • 8.4 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION
    PARKINSON’S DISEASE
    - Rising incidence of Parkinson’s disease and growing R&D to drive market
    TREMORS
    - High efficacy of DBS in treating tremors to drive market
    DEPRESSION
    - Rising research and clinical studies related to depression treatment to propel market
    OTHER DBS APPLICATIONS
  • 8.5 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION
    URINE INCONTINENCE
    - High incidence of urine incontinence to offer growth opportunities for market players
    FECAL INCONTINENCE
    - Reduced symptom recurrence with use of SNS to drive demand
  • 8.6 ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION
    EPILEPSY
    - Advantages associated with VNS in epilepsy treatment to propel market
    OTHER VNS APPLICATIONS
  • 8.7 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION
    GASTROPARESIS
    - Reduced hospitalization time associated with GES treatment to drive market
    OBESITY
    - High prevalence of obesity and risks associated with gastric bypass to propel market
  • 8.8 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION
    TREATMENT-RESISTANT DEPRESSION
    - High prevalence of depression to drive market
    OTHER TENS APPLICATIONS
  • 8.9 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION
    DEPRESSION
    - High effectiveness of TMS and increased acceptance among patients to drive market
    MIGRAINE
    - High prevalence of migraine to support market growth
  • 8.10 ELECTROCEUTICALS MARKET FOR RESPIRATORY ELECTRICAL STIMULATORS, BY APPLICATION
    SPINAL CORD INJURY
    - Rising incidence of spinal cord injuries to fuel demand
  • 8.11 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION
    ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    - Minimal side effects to drive adoption
    MIGRAINE
    - Increasing demand for non-pharmacological treatments to support market growth
ELECTROCEUTICALS MARKET, BY REGION
198
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    US
    - Rising prevalence of cardiovascular and neurological disorders to drive market
    CANADA
    - Rising healthcare expenditure and increasing prevalence of chronic diseases to drive demand
    NORTH AMERICA: RECESSION IMPACT
  • 9.3 EUROPE
    GERMANY
    - Presence of favorable reimbursement policies to drive market
    UK
    - Rising support from government and private organizations to fuel market growth
    FRANCE
    - Promising healthcare reforms to drive market
    ITALY
    - Easy access to healthcare services to create lucrative opportunities for market growth
    SPAIN
    - Increasing number of conferences and awareness programs to support market growth
    REST OF EUROPE
    EUROPE: RECESSION IMPACT
  • 9.4 ASIA PACIFIC
    JAPAN
    - Increasing prevalence of cardiovascular and neurological disorders to drive demand
    CHINA
    - Rising geriatric population to support market growth
    INDIA
    - Developments in healthcare structure to propel market
    REST OF ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
  • 9.5 LATIN AMERICA
    RAPIDLY GROWING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
    LATIN AMERICA: RECESSION IMPACT
  • 9.6 MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Advances in healthcare sector to support market growth
    REST OF MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
307
  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 BRAND/PRODUCT COMPARISON
  • 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
  • 10.7 COMPANY FOOTPRINT
  • 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    PROGRESSIVE COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
  • 10.9 COMPETITIVE BENCHMARKING
  • 10.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
COMPANY PROFILES
323
  • 11.1 KEY PLAYERS
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    LIVANOVA PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    COCHLEAR LTD.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MICROPORT SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    SONOVA
    - Business overview
    - Products offered
    - Recent developments
    NEVRO CORP.
    - Business overview
    - Products offered
    - Recent developments
    AXONICS, INC.
    - Business overview
    - Products offered
    NEURONETICS
    - Business overview
    - Products offered
    - Recent developments
    ELECTROCORE, INC.
    - Business overview
    - Products offered
    - Recent developments
    NEUROPACE, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    BIOTRONIK
    MEDICO S.R.L.
    ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
    MED-EL
    ALEVA NEUROTHERAPEUTICS
    NEUROSIGMA, INC.
    BIOWAVE CORPORATION
    SOTERIX MEDICAL INC.
    BIOINDUCTION (AMBER THERAPEUTICS)
    GIMER MEDICAL
    CEFALY
    BIOCONTROL MEDICAL
    TVNS HEALTH GMBH
APPENDIX
373
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • TABLE 2 RISK ASSESSMENT: ELECTROCEUTICALS MARKET
  • TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES
  • TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022)
  • TABLE 5 AVERAGE SELLING PRICE TREND FOR NEUROMODULATION DEVICES AND PROCEDURES, BY REGION (2022)
  • TABLE 6 ELECTROCEUTICALS MARKET: ROLE IN ECOSYSTEM
  • TABLE 7 ELECTROCEUTICALS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 8 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ELECTROCEUTICALS MARKET
  • TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 13 IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 14 EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 15 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 16 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 17 LIST OF CONFERENCES & EVENTS, 2024–2025
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • TABLE 19 ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 20 KEY PRODUCTS IN CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
  • TABLE 21 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 22 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 23 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 25 MIDDLE EAST & AFRICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 26 KEY PRODUCTS IN COCHLEAR IMPLANTS MARKET
  • TABLE 27 COCHLEAR IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 28 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 29 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 30 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 31 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 32 NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 33 NEUROMODULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 34 NORTH AMERICA: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 35 EUROPE: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: NEUROMODULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 37 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 38 KEY SPINAL CORD STIMULATOR DEVICES AVAILABLE IN MARKET
  • TABLE 39 SPINAL CORD STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 41 EUROPE: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 43 MIDDLE EAST & AFRICA: SPINAL CORD STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 44 KEY DEEP BRAIN STIMULATOR DEVICES AVAILABLE IN MARKET
  • TABLE 45 DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 47 EUROPE: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 49 MIDDLE EAST & AFRICA: DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 50 KEY VAGUS NERVE STIMULATOR DEVICES AVAILABLE IN MARKET
  • TABLE 51 VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 52 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 53 EUROPE: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 55 MIDDLE EAST & AFRICA: VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 56 KEY SACRAL NERVE STIMULATOR DEVICES AVAILABLE IN MARKET
  • TABLE 57 SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 59 EUROPE: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 61 MIDDLE EAST & AFRICA: SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 62 GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 64 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 66 MIDDLE EAST & AFRICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 67 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 69 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 71 MIDDLE EAST & AFRICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 72 TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 74 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 76 MIDDLE EAST & AFRICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 77 RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 79 EUROPE: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 81 MIDDLE EAST & AFRICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 82 TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 84 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 87 RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 89 EUROPE: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 91 MIDDLE EAST & AFRICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 92 RETINAL IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 94 EUROPE: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 96 MIDDLE EAST & AFRICA: RETINAL IMPLANTS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 97 ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 98 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 100 EUROPE: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 103 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 105 EUROPE: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 108 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 109 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 111 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 113 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 115 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 117 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 119 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 121 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 122 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 124 EUROPE: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 126 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 128 EUROPE: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 130 SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 132 EUROPE: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 134 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 135 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 136 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 137 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 139 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 140 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 141 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 143 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 145 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 147 DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 148 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 149 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 151 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 152 SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 153 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 154 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 156 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 158 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 160 ELECTROCEUTICALS MARKET FOR VAGUS NERVE SIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 161 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 162 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 163 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 165 VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 166 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 167 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 169 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 170 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 171 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 172 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 174 GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 175 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 176 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 178 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 179 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 180 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 181 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 183 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 184 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, 2021–2029 (USD MILLION)
  • TABLE 185 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 187 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION
  • TABLE 188 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 189 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 190 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 192 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 193 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 194 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 196 RESPIRATORY ELECTRICAL STIMULATORS MARKET FOR SPINAL CORD INJURY, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 197 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION
  • TABLE 198 TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 199 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 200 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 202 TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 204 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 206 ELECTROCEUTICALS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 207 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 208 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 209 NORTH AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 210 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 211 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 212 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 213 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 214 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 215 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 216 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 217 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 218 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 219 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 220 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 221 US: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 222 US: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 223 US: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 224 US: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 225 US: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 226 US: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 227 US: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 228 US: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 229 US: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 230 US: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 231 US: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 232 NEUROLOGICAL CONDITIONS PREVALENT IN CANADA, 2016–2031
  • TABLE 233 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 234 CANADA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 235 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 236 CANADA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 237 CANADA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 238 CANADA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 239 CANADA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 240 CANADA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 241 CANADA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 242 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 243 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 244 CANADA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 245 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 246 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 247 EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 248 EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 249 EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 250 EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 251 EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 252 EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 253 EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 254 EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 255 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 256 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 257 EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 258 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 259 GERMANY: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 260 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 261 GERMANY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 262 GERMANY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 263 GERMANY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 264 GERMANY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 265 GERMANY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 266 GERMANY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 267 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 268 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 269 GERMANY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 270 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 271 UK: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 272 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 273 UK: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 274 UK: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 275 UK: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 276 UK: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 277 UK: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 278 UK: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 279 UK: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 280 UK: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 281 UK: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 282 FRANCE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 283 FRANCE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 284 FRANCE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 285 FRANCE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 286 FRANCE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 287 FRANCE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 288 FRANCE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 289 FRANCE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 290 FRANCE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 291 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 292 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 293 FRANCE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 294 ITALY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 295 ITALY: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 296 ITALY: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 297 ITALY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 298 ITALY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 299 ITALY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 300 ITALY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 301 ITALY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 302 ITALY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 303 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 304 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 305 ITALY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 306 SPAIN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 307 SPAIN: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 308 SPAIN: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 309 SPAIN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 310 SPAIN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 311 SPAIN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 312 SPAIN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 313 SPAIN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 314 SPAIN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 315 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 316 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 317 SPAIN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 318 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 319 REST OF EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 320 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 321 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 322 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 323 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 324 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 325 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 326 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 327 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 328 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 329 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 332 ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 333 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 334 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 335 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 336 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 337 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 338 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 340 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 341 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 342 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 343 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 344 JAPAN: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 345 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 346 JAPAN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 347 JAPAN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 348 JAPAN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 349 JAPAN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 350 JAPAN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 351 JAPAN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 352 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 353 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 354 JAPAN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 355 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 356 CHINA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 357 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 358 CHINA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 359 CHINA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 360 CHINA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 361 CHINA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 362 CHINA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 363 CHINA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 364 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 365 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 366 CHINA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 367 INDIA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 368 INDIA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 369 INDIA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 370 INDIA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 371 INDIA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 372 INDIA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 373 INDIA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 374 INDIA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 375 INDIA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 376 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 377 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 378 INDIA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 379 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 380 REST OF ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 381 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 382 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 383 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 384 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 385 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 386 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 387 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 388 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 389 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 390 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 391 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 392 LATIN AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 393 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 394 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 395 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 396 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 397 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 398 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 399 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 400 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 401 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 402 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 403 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 404 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 405 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 406 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 407 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 408 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 409 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 410 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 411 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 412 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 413 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 414 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 415 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 416 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 417 GCC COUNTRIES: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 418 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 419 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 420 REST OF MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 421 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 422 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • TABLE 423 ELECTROCEUTICALS MARKET: DEGREE OF COMPETITION
  • TABLE 424 PRODUCT FOOTPRINT
  • TABLE 425 REGIONAL FOOTPRINT
  • TABLE 426 OVERALL COMPANY FOOTPRINT
  • TABLE 427 ELECTROCEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 428 PRODUCT FOOTPRINT (STARTUPS/SMES)
  • TABLE 429 REGIONAL FOOTPRINT (STARTUPS/SMES)
  • TABLE 430 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)
  • TABLE 431 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–JANUARY 2024
  • TABLE 432 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: DEALS, JANUARY 2020–JANUARY 2024
  • TABLE 433 MEDTRONIC: BUSINESS OVERVIEW
  • TABLE 434 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • TABLE 435 ABBOTT: BUSINESS OVERVIEW
  • TABLE 436 LIVANOVA PLC: BUSINESS OVERVIEW
  • TABLE 437 COCHLEAR LTD.: BUSINESS OVERVIEW
  • TABLE 438 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • TABLE 439 SONOVA: BUSINESS OVERVIEW
  • TABLE 440 NEVRO CORP.: BUSINESS OVERVIEW
  • TABLE 441 AXONICS, INC.: BUSINESS OVERVIEW
  • TABLE 442 NEURONETICS: BUSINESS OVERVIEW
  • TABLE 443 ELECTROCORE, INC.: BUSINESS OVERVIEW
  • TABLE 444 NEUROPACE, INC.: BUSINESS OVERVIEW
  • TABLE 445 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 446 MEDICO S.R.L.: COMPANY OVERVIEW
  • TABLE 447 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 448 MED-EL: COMPANY OVERVIEW
  • TABLE 449 ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW
  • TABLE 450 NEUROSIGMA, INC.: COMPANY OVERVIEW
  • TABLE 451 BIOWAVE CORPORATION: COMPANY OVERVIEW
  • TABLE 452 SOTERIX MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 453 BIOINDUCTION (AMBER THERAPEUTICS): COMPANY OVERVIEW
  • TABLE 454 GIMER MEDICAL: COMPANY OVERVIEW
  • TABLE 455 CEFALY: COMPANY OVERVIEW
  • TABLE 456 BIOCONTROL MEDICAL: COMPANY OVERVIEW
  • TABLE 457 TVNS HEALTH GMBH: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 ELECTROCEUTICALS MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (COMPANY REVENUE ESTIMATION APPROACH)
  • FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (SEGMENTAL REVENUE ESTIMATION APPROACH)
  • FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 ELECTROCEUTICALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 ELECTROCEUTICALS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 ELECTROCEUTICALS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 RISING PREVALENCE OF NEUROLOGICAL AND CARDIOVASCULAR DISORDERS TO DRIVE MARKET
  • FIGURE 15 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS WILL CONTINUE TO DOMINATE MARKET IN 2029
  • FIGURE 16 IMPLANTABLE ELECTROCEUTICAL DEVICES TO DOMINATE MARKET IN 2024
  • FIGURE 17 ARRHYTHMIA SEGMENT TO DOMINATE MARKET IN 2029
  • FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN ELECTROCEUTICALS MARKET DURING FORECAST PERIOD
  • FIGURE 19 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 21 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • FIGURE 22 ELECTROCEUTICALS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 ELECTROCEUTICALS MARKET: KEY PLAYERS
  • FIGURE 24 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF CARDIAC PACEMAKERS
  • FIGURE 25 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF NEUROMODULATION PRODUCTS
  • FIGURE 26 REVENUE SHIFT FOR ELECTROCEUTICALS MARKET
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 28 KEY BUYING CRITERIA FOR HOSPITALS
  • FIGURE 29 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT
  • FIGURE 30 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT
  • FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROCEUTICALS MARKET
  • FIGURE 32 ELECTROCEUTICALS MARKET: BRAND COMPARISON, BY KEY PLAYER
  • FIGURE 33 ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  • FIGURE 34 ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/ SMES), 2022
  • FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 37 ABBOTT: COMPANY SNAPSHOT (2022)
  • FIGURE 38 LIVANOVA PLC: COMPANY SNAPSHOT (2022)
  • FIGURE 39 COCHLEAR LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 40 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 41 SONOVA GROUP: COMPANY SNAPSHOT (2022)
  • FIGURE 42 NEVRO CORP.: COMPANY SNAPSHOT (2022)
  • FIGURE 43 AXONICS INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 44 NEURONETICS: COMPANY SNAPSHOT (2022)
  • FIGURE 45 ELECTROCORE, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 46 NEUROPACE, INC.: COMPANY SNAPSHOT (2022)

This study involved four major activities in estimating the current size of the electroceuticals market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the electroceuticals market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, market breakdown and data triangulation were used.

The four steps involved in estimating the market size are:

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the electroceuticals market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the electroceuticals market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as hospitals, clinics and ambulatory surgery centers (ASCs)) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

The following is a breakdown of the primary respondents

Electroceuticals Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various electroceuticals products were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value electroceuticals market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of electroceuticals market at the regional and country-level  
  • Relative adoption pattern of each electroceuticals market among key application segments at the regional and/or country-level   
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country-level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Global Electroceuticals Market Size: Top-Down Approach

Electroceuticals Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the electroceuticals device industry.

Market Definition

Electroceuticals are medical devices that use electrical impulses to modulate the body’s neural circuits as an alternative to drug-based intervention. Electroceuticals, also known as bioelectric medicine, combines molecular medicine, bioengineering, and neuroscience to discover and develop nerve stimulating & sensing technologies to regulate biological processes and treat diseases.

Key Stakeholders

  • Manufacturing Companies of Electroceuticals and Related Devices
  • Original Equipment Manufacturers
  • Suppliers and Distributors of Electroceutical Devices
  • Healthcare Service Providers
  • Teaching Hospitals and Academic Medical Centers (AMCs)
  • Health Insurance Payers
  • Research and Consulting Firms
  • Medical Research Institutes
  • Healthcare Institutes/Providers (Hospitals, Medical Groups, Physicians’ Practices, Diagnostic Centers, and Outpatient Clinics)
  • Venture Capitalists
  • Community Centers

Report Objectives

  • To define, describe, segment, and forecast the global electroceuticals market by product, type, application, and region
  • To forecast the size of the global electroceuticals market with respect to five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall electroceuticals market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To profile the key players in the electroceuticals market and comprehensively analyze their market shares and core competencies2 in terms of market developments and growth strategies
  • To track and analyze competitive developments such as product launches, agreements, collaborations, partnerships, expansions, and acquisitions in the electroceuticals market
  • To benchmark players within the electroceuticals market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Electroceuticals market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa.

Company profiles

  • Product portfolio matrix for leading market players.

Previous Versions of this Report

Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026

Report Code MD 4358
Published in Jun, 2021, By MarketsandMarkets™

Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026

Report Code MD 4358
Published in Jun, 2016, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Electroceuticals Market

David

May, 2022

Research and sales information of Electroceuticals Market / Bioelectric Medicine Market.

Liam

May, 2022

Insights on current market scenario of Bioelectric Medicine Market.

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status